Symbol
| CASP8
| contributors: mct/np - updated : 03-07-2019
|
HGNC name
| caspase 8, apoptosis-related cysteine peptidase
|
HGNC id
| 1509
|
corresponding disease(s)
|
CASP8D
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
|  
| loss of function
|
in neuroblastoma | tumoral
| somatic mutation
|  
|  
|  
|
mutation 1225_1226delTG might lead to the loss of cell death function and contribute to the pathogenesis of hepatocellular carcinomas | tumoral
| somatic mutation
|  
|  
| loss of function
|
inactivated by somatic mutations in advanced gastric carcinomas | constitutional
|  
|  
|  
| loss of function
|
prevented CYLD degradation, resulting in necrotic death | |
Susceptibility
|
contribute to an inherited predisposition to SmCC (small cell carcinoma) of the lung to breast cancer to Alzheimer disease |
Variant & Polymorphism
SNP
| polymorphisms D302H significantly associated with a highly decreased familial breast cancer risk |
|
for CASP8 variants, p.K148R and p.I298V, the association remained significant with Alzheimer disease |
|
|
Candidate gene
Marker
Therapy target
| | | |
| caspase-8-deficient mice exhibit inflammatory skin disorders due to unregulated activation and accumulation of active IRF3 |